|Bid||0.5615 x 1800|
|Ask||0.5863 x 800|
|Day's range||0.5556 - 0.6300|
|52-week range||0.5556 - 3.3600|
|Beta (5Y monthly)||0.46|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Soleno Therapeutics, Inc. (SLNO) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Soleno Therapeutics (SLNO) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.
Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...